Although administration of either atezolizumab or nivolumab alone remarkably decreased tumor sizes, they were less effective than MIT treatment, suggesting the limited efficacy of targeting PD‐L1/PD‐1 in these animals. The gene discussed is PDCD1; the disease is neoplasm.